Staphylococcus aureus has the potential to develop durable vancomycin resistance, according to a new study. Staphylococcus aureus has the potential to develop durable vancomycin resistance, according ...

Pneumococcal resistance to penicillin has made that venerable antibiotic virtually useless for treating community-acquired pneumonia and meningitis. The increasing prevalence of penicillin-resistant ...

November 5, 2009 (Philadelphia, Pennsylvania) — The USA600 strain of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is potentially lethal and is associated with vancomycin resistance, ...

Emergent strain of methicillin-resistant S. aureus (MRSA) that is resistant to last line defense antibiotics has shown a decline, reveals a study. Researchers examined the prevalence of ...

WEST LAFAYETTE, Ind. – Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug ...

Scientists have determined the genome sequences of a dozen strains of Staphylococcus aureus bacteria known to be resistant to vancomycin, an antibiotic of last resort. The researchers demonstrated ...

Multidrug resistant hospital-associated (HA-) and highly virulent community-associated (CA-) methicillin-resistant Staphylococcus aureus (MRSA) have shown increased tolerance or resistance in recent ...

The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Industry has valued at US$ 3.9 billion in 2022 and is anticipated to grow to US$ 5.5 billion by 2030, with sales revenue set to ...

The Morbidity and Mortality Weekly Report (MMWR) series is prepared by the Centers for Disease Control and Prevention (CDC). Often called “the voice of CDC,” the MMWR series is the agency’s primary ...

Vancomycin resistant Staphylococcus aureus (VRSA) radiating from its ancestor show the development of mutants that may someday pose a threat in the clinic. Staphylococcus aureus has the potential to ...